What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey
Patients' experiences of NTM pulmonary disease highlight important and unmet needs for better pharmacological treatment and education of medical staff
Patient experiences; Lung disease
Shteinberg M, Boyd J, Aliberti S, Polverino E, Harris B, Berg T, et al. What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey. ERJ Open Res. 2021 Feb 15;7:00807–2020.
Use this identifier for quote and/or link this documenthttps://hdl.handle.net/11351/7167
This item appears in following collections
- HVH - Articles científics 
The following license files are associated with this item: